Hospira Logo (Lidocaine 01)
Lidocaine Hydrochloride Injection, Solution
Product Images NDC 0409-4283
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0409-4283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula Lidocaine Hydrochloride (Lidocaine 02)
Hospira Logo (Lidocaine 03)
Principal Display Panel (5 mL Ampule Label)
This is a description of a medication with the brand name "SmLSingle". It is only available as a prescription and does not contain preservatives. The medication contains 200mg per 5mL (40mg/mL) and is intended for topical and retrobulbar injection use. It is distributed by Hospira, Inc. in the USA, and has a lot number and expiration date.*
Principal Display Panel (5 mL Ampule Cello Pack Label)
This description is for a single-dose ampuls of Lidocaine HCI, USP, which contains 200 mg/5 mL of lidocaine hydrochloride for topical use and retrobulbar injection. The product is preservative-free and each ampul contains 5mL. The product is distributed by Hospira, Inc. It is recommended to store the product at a temperature between 20 to 25°C (68 to 77°F). The usual dosage is mentioned in the insert.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
